logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
W

Weili Zhao

Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
H指数:29
被引数:8,892

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Zanubrutinib monotherapy in CD79B-mutated relapsed or refractory diffuse large B-cell lymphoma: A multicenter Phase 2 study

zanubrutinib单药治疗<i>CD79B</i>突变复发或难治性弥漫大B细胞淋巴瘤：一项多中心二期研究

HemaSphere
IF14.6
2026-10-170
OAAI
Li Wang; Keshu Zhou; Fei Li; Qingyuan Zhang; Hui Zhou; Ou Bai; Liping Su; Chunhong Hu; Zhi-Ming Li; Kaiyang Ding; Qunyi Guo; Xiaoling Li; Xiaoxi Zhou; Wenjuan Yu; Shuhua Yi; Zhixia Wei; Wenbin Qian; Feiheng Chen; Guohui Cui; Zhiyu Liang; Qingchao Zeng; Jiaoyan Lyu; Yang Liu; Pan Zhang; Zhirong Shen; Zaixing Shi; Jing Rong; Wei-Li Zhao
Real-world treatment patterns and outcomes of brentuximab vedotin–based therapy in CD30-positive lymphomas in China: the prospective BRAVE study

中国CD30阳性淋巴瘤中基于 Brentuximab vedotin 的治疗模式与疗效：前瞻性 BRAVE 研究

Blood Cancer Journal
IF11.6
2026-09-300
OA
Ming-Ci Cai; Ou Bai; Hui-Lai Zhang; Chuan-Xu Liu; Wen-Yang Huang; Li-Hong Liu; Zeng-Jun Li; Lu-Qun Wang; Li-Ping Su; Wei Zhang; Wei Xu; Kai-Yang Ding; Guo-Hui Cui; Hong-Mei Jing; Hua-Qing Wang; Zheng Ge; Fang Zhu; Fei Li; Xiao-Bo Wang; Shen-Miao Yang; Bing Xu; Ying Lu; Yu-Fu Li; Ting Niu; Ke-Qian Shi; Cai-Xia Li; Zhen-Qian Huang; Hong Liu; Ling Qin; Shao-Jie Wu; Hong-Yu Zhang; Jian-Li Wang; Wen-Xin Zhang; Wei-Li Zhao
N6-methyladenosine reader IGF2BP2 in T-cell lymphoma

N6-甲基腺苷识别因子IGF2BP2在T细胞淋巴瘤中

Blood
IF23.1
2026-05-250
PRE
Song Hu; Yao Qin; Hong-Mei Yi; Yao-Hui Huang; Shu Cheng; Cong Wang; Yunqi Li; Yu-Ran Qiu; Ming-Ci Cai; Yan Zhao; Peng-Peng Xu; Li Wang; Jie Xiong; Wei-Li Zhao
CD28+ CD8+ Tem cells with a STAT1-dependent glucocorticoid receptor deficit contribute to steroid-refractory acute GvHD

CD28+ CD8+ Tem细胞通过STAT1依赖的糖皮质激素受体缺陷参与糖皮质激素难治性急性移植物抗宿主病

Blood
IF23.1
2026-04-160
PRE
Zengkai Pan; Yujun Deng; Jingtao Huang; Haoxing Bian; Yiyin Chen; Aijie Huang; Chuanhe Jiang; Luxiang Wang; Zilu Zhang; Haiyang Lu; Su Li; Tong Yin; Shanhe Yu; Jiang Zhu; Wei-Li Zhao; Jianmin Wang; Jie Ji; Yang Xu; Hui Cheng; Jiahao Chen
Author Correction: setd2 knockout zebrafish is viable and fertile: differential and developmental stress-related requirements for Setd2 and histone H3K36 trimethylation in different vertebrate animals

作者更正：Setd2基因敲除斑马鱼具有存活能力和生育能力：不同脊椎动物中Setd2和组蛋白H3K36三甲基化在差异性和发育性应激相关需求上的差异

Cell Discovery
IF12.5
2025-11-170
OAAI
Dian-Jia Liu; Fan Zhang; Yi Chen; Yi Jin; Yuan-Liang Zhang; Shu-Bei Chen; Yin-Yin Xie; Qiu-Hua Huang; Wei-Li Zhao; Lan Wang; Peng-Fei Xu; Zhu Chen; Sai-Juan Chen; Bing Li; Aijun Zhang; Xiao-Jian Sun
18F-fluorodeoxyglucose positron emission tomography/computed tomography as an adjunctive tool in the diagnosis of brain death/ death by neurologic criteria (BD/DNC) with abnormal spinal reflexes: a series of case descriptions

18F-氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描作为诊断脑死亡/神经标准死亡（BD/DNC）伴异常脊髓反射的辅助工具：病例描述系列

QUANTITATIVE IMAGING IN MEDICINE AND SURGERY
IF2.3
2025-10-010
PRE
Cui, Ke; Geng, Caizheng; Yang, Chunyan; Zhao, Weili; Di, Haibo; Laureys, Steven; Xu, Yinghe; Wu, Gang
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial

IELSG37试验中免疫化疗方案对原发性纵隔B细胞淋巴瘤患者预后的影响

Blood
IF23.1
2025-09-150
PRE
Emanuele Zucca; Luca Ceriani; Giovannino Ciccone; Alice Di Rocco; Maria Cristina Pirosa; Iryna Kriachok; Barbara Botto; Monica Balzarotti; Alessandra Tucci; Sara Veronica Usai; Vittorio Ruggero Zilioli; Elsa Pennese; Luca Arcaini; Anna Dabrowska-Iwanicka; Andrés JM Ferreri; Francesco Merli; Weili Zhao; Luigi Rigacci; Claudia Cellini; David Hodgson; Codruta Ionescu; Carla Minoia; Elisa Lucchini; Michele Spina; Alexander Fosså; Andrea Janikova; Kate Cwynarski; N George Mikhaeel; Mats Jerkeman; Anastasios Stathis; Kelly Cozens; Nicoletta Ielmini; Iolanda De Martino; Jan Walewski; Marek Trneny; Franco Cavalli; Umberto Ricardi; Peter WM Johnson; Andrew Davies; Maurizio Martelli
Genetic subtype-guided immunochemotherapy in relapsed and refractory diffuse large B cell lymphoma: a phase 2 investigator-initiated nonrandomized clinical trial (GUIDANCE-06)

遗传亚型指导的免疫化疗治疗复发和难治性弥漫性大b细胞淋巴瘤: 研究者启动的2期非随机临床试验 (GUIDANCE-06)

Signal Transduction and Targeted Therapy
IF52.7
2025-07-260
OAAI
Yi-Ge Shen; Qing Shi; Wei Tang; Peng-Peng Xu; Yi-Wen Cao; Meng-Meng Ji; Zhong Zheng; Shu Cheng; Li Wang; Wei-Li Zhao

研究方向

暂未获取到该数据
S
Shu Cheng
H 指数:22论文数:169被引数:2,123
P
Pengpeng Xu
H 指数:25论文数:171被引数:2,254
王理 封面图
王理
H 指数:25论文数:129被引数:2,136
H
Hongmei Yi
H 指数:15论文数:80被引数:904
D
Di Fu
H 指数:22论文数:132被引数:2,137
Q
Qing Shi
H 指数:13论文数:57被引数:989
T
Ting Niu
H 指数:36论文数:491被引数:5,333
熊
熊杰
H 指数:22论文数:90被引数:1,696
L
Lei Dong
H 指数:16论文数:96被引数:975
X
Xufeng Jiang
H 指数:16论文数:120被引数:822